Related Experiment Video
Updated: Aug 17, 2026

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library
Published on: January 10, 2025
Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis
Yang Du1, Sally E Spence, Nancy A Jenkins
1Mouse Cancer Genetics Program, National Cancer Institute, Center for Cancer Research, Frederick, MD, USA.
Abstract:
Multiple cooperating mutations that deregulate different signaling pathways are required to induce cancer. Identifying these cooperating mutations is a prerequisite for developing better combinatorial therapies for treating cancer. Here we show that cooperating cancer mutations can be identified through oncogenic-retrovirus-induced insertional mutagenesis. Among 13 myeloid leukemias induced by transplanting into mice bone marrow cells infected in vitro with a replication-defective retrovirus carrying the Sox4 oncogene, 9 contained insertional mutations at known or suspected cancer genes. This likely occurred because rare bone marrow cells, in which the oncogenic retrovirus happened to integrate and in which it mutated a cooperating cancer gene, were selected because the host harbored a cooperating cancer mutation. Cooperativity between Sox4 and another gene, Mef2c, was subsequently confirmed in transplantation studies, in which deregulated Mef2c expression was shown to accelerate the myeloid leukemia induced by Sox4. Insertional mutagenesis of cooperating cancer genes by a defective oncogenic retrovirus provides a new method for identifying cooperating cancer genes and could aid in the development of better therapies for treating cancer.
Insights
Identifying cooperating cancer mutations is key for developing new cancer therapies. This study shows oncogenic retroviruses can identify these mutations, aiding in the development of novel combinatorial cancer treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer development requires multiple cooperating mutations affecting various signaling pathways.
- Identifying these cooperating mutations is crucial for designing effective combinatorial cancer therapies.
Purpose of the Study:
- To investigate the use of oncogenic-retrovirus-induced insertional mutagenesis for identifying cooperating cancer mutations.
- To confirm cooperativity between the Sox4 oncogene and other cancer genes in myeloid leukemia.
Main Methods:
- Utilized replication-defective retroviruses carrying the Sox4 oncogene for insertional mutagenesis in mouse bone marrow cells.
- Induced myeloid leukemias in mice and analyzed insertional mutations in cancer-related genes.
- Performed transplantation studies to confirm gene cooperativity and its effect on leukemia acceleration.
Main Results:
- Out of 13 induced myeloid leukemias, 9 exhibited insertional mutations in known or suspected cancer genes.
- Demonstrated cooperativity between Sox4 and Mef2c, where deregulated Mef2c accelerated Sox4-induced myeloid leukemia.
- Showcased that insertional mutagenesis by defective oncogenic retroviruses can identify cooperating cancer genes.
Conclusions:
- Oncogenic-retrovirus-induced insertional mutagenesis is a viable method for identifying cooperating cancer genes.
- This approach can accelerate the discovery of gene cooperation in cancer development.
- The findings support the development of improved combinatorial therapies for cancer treatment.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Non-LTR Retrotransposons
In-vitro Mutagenesis

